C. Frassineti

发表

In Vivo Assessment of Free Magnesium Concentration in Human Brain by 31P MRS. A New Calibration Curve Based on a Mathematical Algorithm

B. Barbiroli, S. Iotti, C. Frassineti, 1996, NMR in biomedicine.

Muscle phosphoglycerate mutase (PGAM) deficiency in the first Caucasian patient: biochemistry, muscle culture and31P-MR spectroscopy

N. Bresolin, P. Zaniol, B. Barbiroli, 1994, Journal of Neurology.

Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells.

Maria Paola Costi, S. Piras, P. Corona, 2009, European journal of pharmacology.

Defective brain and muscle energy metabolism shown by in vivo 31P magnetic resonance spectroscopy in nonaffected carriers of 11778 mtDNA mutation

P. Zaniol, B. Barbiroli, P. Barboni, 1995, Neurology.

31P‐Magnetic resonance spectroscopy in migraine without aura

P. Zaniol, R. Lodi, P. Cortelli, 1994, Neurology.

Characterization of the cell growth inhibitory effects of a novel DNA-intercalating bipyridyl-thiourea-Pt(II) complex in cisplatin-sensitive and—resistant human ovarian cancer cells

M. G. Monti, F. Wolf, M. Montanari, 2011, Investigational New Drugs.

in vivo assessment of mitochondrial functionality in human gastrocnemius muscle by 31P MRS. The role of pH in the evaluation of phosphocreatine and inorganic phosphate recoveries from exercise

P. Zaniol, B. Barbiroli, R. Lodi, 1993, NMR in biomedicine.

Quantitative mathematical expressions for accurate in vivo assessment of cytosolic [ADP] and DeltaG of ATP hydrolysis in the human brain and skeletal muscle.

B. Barbiroli, S. Iotti, C. Frassineti, 2005, Biochimica et biophysica acta.

Studies on the anti-proliferative effects of novel DNA-intercalating bipyridyl-thiourea-Pt(II) complexes against cisplatin-sensitive and -resistant human ovarian cancer cells.

M. Bergomi, C. Frassineti, M. D. Di Pietro, 2008, Journal of inorganic biochemistry.

Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells.

Maria Paola Costi, M. G. Monti, C. Frassineti, 2013, International journal of oncology.

Distamycin A and derivatives as synergic drugs in cisplatin-sensitive and -resistant ovarian cancer cells

Maria Paola Costi, M. G. Monti, C. Frassineti, 2011, Amino Acids.

KLF4 Mediates the Effect of 5-ASA on the β-Catenin Pathway in Colon Cancer Cells

C. Gemelli, S. Ferrari, B. Calabretta, 2018, Cancer Prevention Research.

Nuclear magnetic resonance as a tool for determining protonation constants of natural polyprotic bases in solution.

P. Gans, S. Ghelli, C. Frassineti, 1995, Analytical biochemistry.

Magnesium Is a Key Regulator of the Balance between Osteoclast and Osteoblast Differentiation in the Presence of Vitamin D3

S. Castiglioni, S. Iotti, C. Frassineti, 2019, International journal of molecular sciences.

In vivo (31)P-MRS assessment of cytosolic [Mg(2+)] in the human skeletal muscle in different metabolic conditions.

B. Barbiroli, S. Iotti, C. Frassineti, 2000, Magnetic resonance imaging.

Determination of protonation constants of some fluorinated polyamines by means of 13C NMR data processed by the new computer program HypNMR2000. Protonation sequence in polyamines

P. Gans, S. Ghelli, C. Frassineti, 2003, Analytical and bioanalytical chemistry.

Structure-activity relationships in dihydropteroate synthase inhibition by sulfanilamides. Comparison with the antibacterial activity.

P. D. De Benedetti, C. Frassineti, A. Rastelli, 1981, Journal of medicinal chemistry.

Experimental and theoretical study of electronic substituent effects in 4-aminoaryl (4-substituted aryl) sulphones

C. Frassineti, D. Iarossi, P. Benedetti, 1985 .

DISCO--a general computer program for the computation of acid dissociation constants of polyprotic molecules in water and biological fluids, from nuclear magnetic resonance data: application to polyamines.

F. Reniero, C. Guillou, S. Ghelli, 2003, Analytical biochemistry.

Distamycin A and derivatives as synergic drugs in cisplatin-sensitive and -resistant ovarian cancer cells

Maria Paola Costi, M. G. Monti, C. Frassineti, 2012, Amino Acids.

Spermidine/spermine N1-acetyltranferase modulation by novel folate cycle inhibitors in cisplatin-sensitive and -resistant human ovarian cancer cell lines.

Maria Paola Costi, M. G. Monti, S. Piras, 2010, Gynecologic oncology.

Synthesis, chemical and biological studies on new Fe(3+)-glycosilated beta-diketo complexes for the treatment of iron deficiency.

M. Saladini, C. Frassineti, M. Ferrali, 2008, European journal of medicinal chemistry.

Small hyperechoic nodules of the renal parenchyma

C. Frassineti, F. Zappasodi, G. Sanna, 1985, Journal of clinical ultrasound : JCU.

Internalization and stability of a thymidylate synthase Peptide inhibitor in ovarian cancer cells.

Maria Paola Costi, G. Ponterini, G. Cannazza, 2014, Journal of medicinal chemistry.

Inhibition of cell growth by accumulated spermine is associated with a transient alteration of cell cycle progression.

M. G. Monti, L. Pernecco, R. Manfredini, 1996, Life sciences.

Effect of spermine on membrane-associated and membrane-inserted forms of protein kinase C

M. G. Monti, C. Frassineti, G. Marverti, 1993, Molecular and Cellular Biochemistry.

The effect of spermine on calcium requirement for protein kinase C association with phospholipid vesicles.

M. G. Monti, C. Frassineti, G. Marverti, 1995, The international journal of biochemistry & cell biology.

Coenzyme Q10 improves mitochondrial respiration in patients with mitochondrial cytopathies. An in vivo study on brain and skeletal muscle by phosphorous magnetic resonance spectroscopy.

B Barbiroli, B. Barbiroli, R. Lodi, 1997, Cellular and molecular biology.

A theoretical study of the structure—Activity relationship in diaryl sulphones, comparison with sulpha drugs

C. Frassineti, P. Benedetti, 1983 .

Correlation and multivariate analyses of the spectroscopic data in 4′-substituted 4-nitrodiphenylsulfones

M. Cocchi, M. Menziani, C. Frassineti, 1991 .

Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase

Maria Paola Costi, Daniela Cardinale, Giambattista Guaitoli, 2011, Proceedings of the National Academy of Sciences.

Unexpected Absence of Skeletal Responses to Dietary Magnesium Depletion: Basis for Future Perspectives?

F. Rizzi, C. Frassineti, M. Ferretti, 2023, Biomedicines.

Quantitative structure-activity relationships in dihydropteroate synthase inhibition by multisubstituted sulfones. Design and synthesis of some new derivatives with improved potency.

M. Menziani, P. D. De Benedetti, C. Frassineti, 1989, Journal of medicinal chemistry.

Quantitative structure-activity analysis in dihydropteroate synthase inhibition by sulfones. Comparison with sulfanilamides.

V. Caiolfa, P. D. De Benedetti, C. Frassineti, 1987, Journal of medicinal chemistry.

Comparative QSAR analysis in dihydropteroate synthase inhibition by sulphones. Design and synthesis of some new derivatives with improved potency.

M. Cocchi, M. Menziani, P. D. De Benedetti, 1989, Progress in clinical and biological research.

A Quantum Chemical QSAR Study of Carbonic Anhydrase Inhibition by Sulfonamides Sulfonamide Carbonic Anhydrase Inhibitors: Quantum Chemical QSAR

M. Menziani, C. Frassineti, P. Benedetti, 1985 .

A theoretical study of conformation-electronic structure relationships in benzensulfonamide inhibitors of the carbonic anhydrase enzyme

M. Cocchi, M. Menziani, C. Frassineti, 1989 .

Multinuclear NMR and vibrational spectroscopy studies of the substituent effects in benzensulphonamide inhibitors of the enzyme carbonic anhydrase

M. Menziani, C. Frassineti, D. Iarossi, 1988 .

A Quantum Chemical QSAR Analysis of Carbonic Anhydrase Inhibition by Heterocyclic Sulfonamides. Sulfonamide Carbonic Anhydrase Inhibitors: Quantum Chemical QSAR

M. Cocchi, M. Menziani, C. Frassineti, 1987 .

Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells.

Maria Paola Costi, S. Piras, P. Corona, 2009, European journal of pharmacology.